| Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples K Dheda, V Davids, L Lenders, T Roberts, R Meldau, D Ling, L Brunet, ... PloS one 5 (3), e9848, 2010 | 194 | 2010 |
| Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? DI Ling, M Pai, V Davids, L Brunet, L Lenders, R Meldau, G Calligaro, ... European Respiratory Journal 38 (3), 649-656, 2011 | 108 | 2011 |
| Weight gain before and after switch from TDF to TAF in a US cohort study PWG Mallon, L Brunet, RK Hsu, JS Fusco, KC Mounzer, G Prajapati, ... African Journal of Reproduction and Gynaecological Endoscopy 24 (4), e25702, 2021 | 94 | 2021 |
| The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics RN van Zyl-Smit, L Brunet, M Pai, WW Yew Infectious Disease Clinics 24 (3), 693-703, 2010 | 89 | 2010 |
| High prevalence of smoking among patients with suspected tuberculosis in South Africa L Brunet, M Pai, V Davids, D Ling, G Paradis, L Lenders, R Meldau, ... European Respiratory Journal 38 (1), 139-146, 2011 | 87 | 2011 |
| Marijuana smoking does not accelerate progression of liver disease in HIV–hepatitis C coinfection: a longitudinal cohort analysis L Brunet, EEM Moodie, K Rollet, C Cooper, S Walmsley, M Potter, ... Clinical Infectious Diseases 57 (5), 663-670, 2013 | 85 | 2013 |
| HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study K Mounzer, R Hsu, JS Fusco, L Brunet, CE Henegar, V Vannappagari, ... AIDS research and therapy 16, 1-9, 2019 | 59 | 2019 |
| New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations T Davy-Mendez, JJ Eron, L Brunet, O Zakharova, AM Dennis, S Napravnik Aids 32 (17), 2593-2603, 2018 | 29 | 2018 |
| Lipid changes after switch from TDF to TAF in the OPERA cohort: LDL cholesterol and triglycerides PWG Mallon, L Brunet, JS Fusco, G Prajapati, A Beyer, GP Fusco, ... Open Forum Infectious Diseases 9 (1), ofab621, 2022 | 26 | 2022 |
| Tobacco smoking is not associated with accelerated liver disease in human immunodeficiency virus-hepatitis C coinfection: a longitudinal cohort analysis CT Costiniuk, L Brunet, KC Rollet-Kurhajec, CL Cooper, SL Walmsley, ... Open Forum Infectious Diseases 3 (2), ofw050, 2016 | 20 | 2016 |
| Advanced HIV infection in treatment-naïve individuals: effectiveness and persistence of recommended 3-drug regimens K Mounzer, L Brunet, JS Fusco, IR Mcnicholl, H Diaz Cuervo, M Sension, ... Open Forum Infectious Diseases 9 (3), ofac018, 2022 | 19 | 2022 |
| Weight gain before and after switch from TDF to TAF P Mallon, L Brunet, R Hsu, J Fusco, K Mounzer, G Prajapati, A Beyer, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 23, 25-26, 2020 | 14 | 2020 |
| Fluorescent light emitting diode (LED) microscopy for the detection of Mycobacterium tuberculosis: a systematic review and meta-analysis J Minion, L Brunet, M Pai, M Pai World Health Organization. Approaches to improve sputum smear microscopy for …, 2009 | 14 | 2009 |
| Brief report: Longitudinal opioid use among HIV-infected patients, 2000 to 2014 L Brunet, S Napravnik, AD Heine, PA Leone, JJ Eron JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (1), 77-80, 2017 | 13 | 2017 |
| Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs R Hsu, L Brunet, JS Fusco, K Mounzer, V Vannappagari, CE Henegar, ... Aids 35 (1), 81-90, 2021 | 12 | 2021 |
| Opioid use and risk of liver fibrosis in HIV/hepatitis C virus‐coinfected patients in C anada L Brunet, EEM Moodie, J Cox, J Gill, C Cooper, S Walmsley, A Rachlis, ... HIV medicine 17 (1), 36-45, 2016 | 12 | 2016 |
| Changes in body mass index associated with antiretroviral regimen switch among treatment-experienced, virologically suppressed people living with HIV in the United States K Mounzer, L Brunet, R Hsu, J Fusco, V Vannappagari, C Henegar, ... AIDS research and human retroviruses 37 (11), 852-861, 2021 | 11 | 2021 |
| Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes RK Hsu, JS Fusco, CE Henegar, V Vannappagari, A Clark, L Brunet, ... BMC Infectious Diseases 23 (1), 91, 2023 | 10 | 2023 |
| Changes in BMI associated with antiretroviral regimens in treatment-experienced, virologically suppressed individuals living with HIV K Mounzer, L Brunet, R Hsu, T Fatukasi, JS Fusco, V Vannappagari ID Week, Washington, DC, 2019 | 10 | 2019 |
| Cabotegravir+ rilpivirine long-acting injections for HIV treatment in the US: real world data from the OPERA cohort MG Sension, L Brunet, RK Hsu, JS Fusco, Q Cochran, C Uranaka, ... Infectious Diseases and Therapy 12 (12), 2807-2817, 2023 | 9 | 2023 |
